Prompt Pattern Engineering for Test Question Mapping Using ChatGPT: A Cross-Sectional Study.

Objective: This study aimed to develop a prompt engineering procedure for test question mapping and then determine the effectiveness of test question mapping using Chat Generative Pre-Trained Transformer (ChatGPT) compared to human faculty mapping.

Methods: We conducted a cross-sectional study to compare ChatGPT and human mapping using a sample of 139 test questions from modules within the Integrated Pharmacotherapeutics course series. The test questions were mapped by 3 faculty members to both module objectives and the Accreditation Council for Pharmacy Education Standards 2016 (Standards 2016) to create the "correct answer".

Positive Association between Peri-Surgical Opioid Exposure and Post-Discharge Opioid-Related Outcomes.

Background: Multiple studies have investigated the epidemic of persistent opioid use as a common postsurgical complication. However, there exists a knowledge gap in the association between the level of opioid exposure in the peri-surgical setting and post-discharge adverse outcomes to patients and healthcare settings. We analyzed the association between peri-surgical opioid exposure use and post-discharge outcomes, including persistent postsurgical opioid prescription, opioid-related symptoms (ORS), and healthcare resource utilization (HCRU).

Assessing pharmacy student confidence to answer patient questions regarding herbal medicines and natural product drugs.

Background And Purpose: To assess the change in confidence answering questions about herbal medicines and natural product drugs (HMNPD) in third year professional pharmacy students in an HMNPD course.

Educational Activity And Setting: A questionnaire was developed to query confidence in responding to patient questions, recommending specific products, and ability to retrieve resources regarding HMNPD. It was administered the first and last week of the semester; responses were evaluated using a Chi-squared test.

Laboratory Monitoring of Low-Molecular-Weight Heparin and Fondaparinux.

Compared with older agents, low-molecular-weight heparins (LMWH) and fondaparinux offer improved bioavailability and more predictable, dose-independent clearance. While routine monitoring of coagulation parameters is not usually necessary with these agents, certain populations (including pregnant patients, children, obese patients, and patients with renal impairment) may benefit from the monitoring of anti-factor Xa activity, thromboelastography, or other coagulation assays to help guide therapy. The chromogenic anti-factor Xa assay is currently the gold standard for monitoring LMWH and fondaparinux therapy.